Medicare Part D Plans Show Modest Premium Cuts and Higher Deductibles Following Inflation Reduction Act
Source Summary
A study published in Health Affairs examined how Medicare Part D insurers responded to the 2022 Inflation Reduction Act. Researchers found that insurers primarily lowered premiums while increasing deductibles across both Medicare Advantage plans with drug coverage and stand-alone prescription drug plans.
Why it matters
The findings demonstrate how federal drug pricing legislation directly influences insurer plan design decisions and cost-sharing structures for Medicare beneficiaries.
